Heparinex is categorized under Pharmaceutical Machinery Manufacturers in Oklahoma City, OK and active since 2010.
Heparinex was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Pharmaceutical Machinery Manufacturers business, which does work in the B2B market, and is classified as a Pharmaceutical Machinery Manufacturers, under code number 333249 by the NAICS.
If you are seeking more information, feel free to contact Thomas Harlan at the company’s single location by writing to 655 Research Parkway, Oklahoma City, Oklahoma OK 73104 or by phoning (405) 271-1544. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Heparinex |
| Contact Person: | Thomas Harlan |
| Address: | 655 Research Parkway, Oklahoma City, Oklahoma 73104 |
| Phone Number: | (405) 271-1544 |
| Website Address: | heparinex.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Pharmaceutical Machinery Manufacturers |
| SIC Code: | 3559 |
| NAICS Code: | 333249 |
| Share This Business: |
Heparinex was started in 2010 to provide professional Pharmaceutical Machinery Manufacturers under the SIC code 3559 and NAICS code 333249. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Thomas Harlan for inquiries that concern Heparinex by calling the company number (405) 271-1544, as your correspondence is most welcome. Additionally, the physical location of the single location of Heparinex can be found at the coordinates 35.472887,-97.503546 as well as the street address 655 Research Parkway in Oklahoma City, Oklahoma 73104.
For its online presence, you may visit Heparinex’s website at heparinex.com and engage with its social media outlets through on Twitter and on Facebook.